02279 YONGHE MEDICAL
Closed Add to PorfolioKey Financial Ratio (Fiscal Year: 12/2024) | |||
Current | 1.15X | Oper Margin | N/A |
---|---|---|---|
LT Debt/Equity | 65.3% | Net Margin | N/A |
Total Debt/Equity | 93.4% | Return on Equity | N/A |
Price/Book | 1.93X | Return on Assets | N/A |
(HKD 2.790) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
Net Profit (MHKD) | -240.72 | -592.83 | -94.15 | 143.80 | 174.42 |
---|---|---|---|---|---|
Net Profit Growth (%) | +59.4 | -529.6 | -165.5 | -17.6 | +338.0 |
Earnings Per Share (HKD) | -0.481 | -1.194 | -0.184 | 0.359 | 0.464 |
Earnings Per Share Growth (%) | +59.8 | -550.4 | -151.2 | -22.7 | +365.9 |
Dividend Per Share (HKD) | No dividend | No dividend | No dividend | 0.093 | No dividend |
P/E* (X) | N/A | N/A | N/A | 7.78 | 6.01 |
Yield (%) | N/A | N/A | N/A | 3.33 | N/A |
Dividend Share (%) | N/A | N/A | N/A | 25.92 | N/A |
Book NAV (HKD) | 1.446 | 1.971 | 3.372 | 3.995 | N/A |
Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | N/A |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-09-08 21:40:20
Latest Result
(RMBMn) | 2025-06 | 2024-06 | Chg* (%) | 2023-06 |
Cover Period (mths) | 6 | 6 | NA | 6 |
---|---|---|---|---|
Turnover | 861.55 | 900.203 | -4.3 | 827.807 |
Operating Result | 42.546 | -112.683 | -137.8 | -252.447 |
Profit Before Taxation | 37.809 | -146.699 | -125.8 | -256.428 |
Taxation | 9.954 | -8.051 | -223.6 | -30.237 |
Profit /( Loss) After Taxation | 27.855 | -138.648 | -120.1 | -226.191 |
Minority Interests | -0.058 | -0.076 | -23.7 | 0 |
Net Profit | 27.913 | -136.402 | -120.5 | -221.103 |
Earnings Per Share () | 0.0611 | -0.2974 | -120.5 | -0.4754 |
Announcement Date | 2025-08-27 | 2024-08-22 | NA | 2023-08-25 |
* Annualised
Last Update Time: 2025-09-08 21:40:25